Livzon Pharmaceutical Group Inc. (Livzon Pharma) has issued a notice to convene its first Extraordinary General Meeting (EGM) of 2026 on 24 September 2026 at 2:00 p.m. in Zhuhai, Guangdong. The single agenda item is an ordinary resolution to approve a 2026 Special Interim Dividend for shareholders.
Key timetable • 18 Sep 2026 – Record date for determining shareholders entitled to attend and vote at the EGM. • 24 Sep 2026 – EGM date; exchange rate for HKD dividend conversion to be fixed at the PBOC RMB/HKD central parity rate on this date. • 13 Oct 2026 – Record date for A-share holders entitled to the Special Interim Dividend. • 15 Oct 2026 – Record date for H-share holders entitled to the Special Interim Dividend; deadline (4:30 p.m.) for lodging H-share transfer documents with Tricor Investor Services.
Dividend currency • A-share investors will receive the Special Interim Dividend in renminbi (RMB). • H-share investors will receive the dividend in Hong Kong dollars, converted from RMB at the 24 September 2026 PBOC central parity rate.
Tax treatment • Overseas individual H-shareholders: 20% individual income tax to be withheld by the company, in line with MOF and SAT Announcement 2026-No. 27. • Non-resident enterprise H-shareholders: 10% corporate income tax to be withheld under Guo Shui Han [2008] No. 897. • Southbound Trading Link investors: domestic individuals and securities investment funds subject to a 20% withholding; domestic enterprise investors to self-declare and pay taxes.
Shareholders may appoint one or more proxies to attend and vote, with proxy forms due 24 hours before the meeting. Completion of a proxy form does not preclude shareholders from attending the meeting in person.
Livzon Pharma’s board currently comprises two executive directors, three non-executive directors, one employee representative director, and four independent non-executive directors.